Lv21
176 积分 2026-02-25 加入
中华医学会肿瘤学分会肺癌临床诊疗指南(2026版)
3小时前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breas tcancer:arandomized phase 3 trial
1个月前
已完结
Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer
1个月前
已完结
A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) ingastric or gastroesophageal junction adenocarcinoma (G/GEJA): Trial in progress
2个月前
已完结
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
6个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
6个月前
已完结
皖公网安备34019202002308
